Search Results - "Meyer, Carsten H."

Refine Results
  1. 1
  2. 2

    Intraocular Pharmacokinetics of Ranibizumab Following a Single Intravitreal Injection in Humans by Krohne, Tim U, Liu, Zengping, Holz, Frank G, Meyer, Carsten H

    Published in American journal of ophthalmology (01-10-2012)
    “…Purpose To investigate intraocular concentrations and pharmacokinetics of ranibizumab after a single intravitreal injection in humans. Design Prospective,…”
    Get full text
    Journal Article
  3. 3
  4. 4

    Intraocular Pharmacokinetics of Bevacizumab After a Single Intravitreal Injection in Humans by Krohne, Tim U, Eter, Nicole, Holz, Frank G, Meyer, Carsten H

    Published in American journal of ophthalmology (01-10-2008)
    “…Purpose To investigate intraocular concentrations and pharmacokinetics of bevacizumab after a single intravitreal injection in humans. Design Prospective,…”
    Get full text
    Journal Article
  5. 5

    Off-label use of intravitreal bevacizumab: A global conundrum by Singh, Samya, Saxena, Sandeep, Akduman, Levent, Meyer, Carsten H

    Published in Indian journal of ophthalmology (01-05-2024)
    “…Bevacizumab is a monoclonal, humanized, full-length antibody targeting vascular endothelial growth factor(VEGF-A), known for its anti-angiogenic properties…”
    Get full text
    Journal Article
  6. 6

    Clinical use and research applications of Heidelberg retinal angiography and spectral-domain optical coherence tomography - a review by Hassenstein, Andrea, Meyer, Carsten H.

    Published in Clinical & experimental ophthalmology (01-01-2009)
    “…Fluorescein angiography (FA) was discovered by Nowotny and Alvis in the 1960s of the 20th century and has evolved to become the ‘Gold standard’ for macular…”
    Get full text
    Journal Article
  7. 7

    Serum vascular endothelial growth factor is a biomolecular biomarker of severity of diabetic retinopathy by Ahuja, Sukriti, Saxena, Sandeep, Akduman, Levent, Meyer, Carsten H, Kruzliak, Peter, Khanna, Vinay K

    “…Elevated serum vascular endothelial growth factor (VEGF) levels are associated with diabetic retinopathy (DR). Serum VEGF levels correlate with vitreous…”
    Get full text
    Journal Article
  8. 8

    Monitoring of central corneal thickness after phacoemulsification—comparison of statical and rotating Scheimpflug pachymetry, and spectral-domain OCT by Handzel, Daniel M., Wegener, Alfred

    Published in International journal of ophthalmology (18-08-2022)
    “…AIM: To explore the possibility of deploying three contactless devices (static and rotating Scheimpflug technology, spectral domain optical coherence…”
    Get full text
    Journal Article
  9. 9

    Can intravitreal injections with higher volume cause higher intraocular eye pressure? Considerations for anti-complement injections in normal and glaucomatous eyes by Meyer, Carsten H, Melo, Gustavo Barreto, Khanani, Arshad M

    “…The approval of Syfovre® (pegcetacoplan) and Iverzay® (avacincaptad pegol) for the treatment of geographic atrophy (GA) marks a significant advancement in…”
    Get full text
    Journal Article
  10. 10
  11. 11

    External limiting membrane: retinal structural barrier in diabetic macular edema by Saxena, Sandeep, Akduman, Levent, Meyer, Carsten H

    “…Advances in spectral-domain optical coherence tomography (SD-OCT) technology have enhanced the understanding of external limiting membrane (ELM) and ellipsoid…”
    Get full text
    Journal Article
  12. 12
  13. 13

    Serum vitamin D is a biomolecular biomarker for proliferative diabetic retinopathy by Nadri, Gauhar, Saxena, Sandeep, Mahdi, Abbas Ali, Kaur, Apjit, Ahmad, Md Kaleem, Garg, Pragati, Meyer, Carsten H

    “…Vitamin D is a multi-functional fat-soluble metabolite essential for a vast number of physiological processes. Non-classical functions are gaining attention…”
    Get full text
    Journal Article
  14. 14
  15. 15

    The potential of spectral domain optical coherence tomography imaging based retinal biomarkers by Phadikar, Prateep, Saxena, Sandeep, Ruia, Surabhi, Lai, Timothy Y Y, Meyer, Carsten H, Eliott, Dean

    “…Biomarker", a merged word of "biological marker", refers to a broad subcategory of medical signs that objectively indicate the state of health, and well-being…”
    Get full text
    Journal Article
  16. 16

    Incidence of rhegmatogenous retinal detachments after intravitreal antivascular endothelial factor injections by Meyer, Carsten H., Michels, Stephan, Rodrigues, Eduardo B., Hager, Annette, Mennel, Stefan, Schmidt, Jörg C., Helb, Hans‐Martin, Farah, Michel E.

    Published in Acta ophthalmologica (Oxford, England) (01-02-2011)
    “…Acta Ophthalmol. 2011: 89: 70–75 . Purpose:  To determine the incidence of rhegmatogenous retinal detachments (RD) after intravitreal injection in six…”
    Get full text
    Journal Article
  17. 17
  18. 18
  19. 19

    Vitrectomy in full thickness macular holes on top of a pigment epithelial detachment in age-related macular degeneration (AMD). Surgical consideration and review of the literature by Meyer, Paula S., Kammann, Marc T., Meyer, Carsten H.

    “…To present the surgical treatment of a full thickness macular hole (MH) caused by a vitreomacular traction (VMT) on top of an adjacent subfoveal pigment…”
    Get full text
    Journal Article
  20. 20

    Subretinal fluid application to close a refractory full thickness macular hole by Meyer, Carsten H, Borny, Robert, Horchi, Nicole

    “…To close a refractory full thickness macular hole (FTMH) by adjacent subretinal fluid application to release the elastic retina from the retinal pigment…”
    Get full text
    Journal Article